Patent AnalyticsExaminers
Rankings

Company or institution

AMGEN K-A, INC.

19 applicationsfiled 2007 to 2023

Allowance rate
83%
+8 pts vs the USPTO range 61% to 94%
Rejections before allowance
1.6
level with the USPTO
Months to first action
17.6 mo
−1.0 vs the USPTO
Needed an RCE
33%
+6 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations16 apps
C07K Peptides3 apps

Art units

164313 apps
16465 apps
16741 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
18530387IL-17 RECEPTOR A ANTIGEN BINDING PROTEINS2023-12-06Pending1031.5 mo
18045534METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION2022-10-11Abandoned2037.7 mo
17015029METHOD OF TREATING DISEASES USING AN IL-17 RECEPTOR ANTIBODY FORMULATION2020-09-08Allowed1014.3 mo
15175333Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15162376Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15842535Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15967889Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15337188Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15181183Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15150586Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 19 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in